Flex Biomedical, Inc.

MADISON, WI · Founded 2007 · Medtech · Private

Biodegradable medical devices and implants made from flexible polymeric materials

Claim this profile

Follows are private to you and power your alerts

Updated · flexbiomedical.com

Sector
Medtech
Headquarters
MADISON, WI
Founded
2007
Latest Form D
$882K, Jun 2012
Total capital
$2.4M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$2.4M
3 Form D · last Jun 2012
172 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

2009201020112012FEDERAL ↑EQUITY ↓Cumulative $2.4M1st Form D$812K2nd Form D$694K3rd Form D$882K
2009201020112012FEDERAL ↑EQUITY ↓Cumulative $2.4M1st Form D$812K3rd Form D$882K

Latest events

  • Private capital raisedForm D · SEC · 3rd filing$882K
  • Private capital raisedForm D · SEC · 2nd filing$694K
  • Private capital raisedForm D · SEC · 1st filing$812K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Founders and team

From SEC Form D filings
  • David C. SneiderDirectorNamed in SEC Form D filings
  • Donald R. UrbanowiczDirectorNamed in SEC Form D filings
  • Hideki C. Suzuki, PhDExecutive OfficerNamed in SEC Form D filings
  • Mark P. GrinstaffDirectorNamed in SEC Form D filings
  • Michael C. Wathier, PhDExecutive OfficerNamed in SEC Form D filings
  • Nicholas E. Mischler, MDDirectorNamed in SEC Form D filings
Show all 8 people
  • Salvatore P. BraicoExecutive Officer, DirectorNamed in SEC Form D filings
  • Steven R. Pollock, RPh, MBADirectorNamed in SEC Form D filings

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .